Impact of COVID-19 pandemic on epilepsy care in Japan: A national-level multicenter retrospective cohort study.
Naoto KurodaTakafumi KubotaToru HorinouchiNaoki IkegayaYu KitazawaSatoshi KodamaIzumi KuramochiTeppei MatsubaraNaoto NaginoShuichiro NeshigeTemma SogaYutaro TakayamaDaichi Sonenull nullKousuke KanemotoAkio IkedaKiyohito TeradaHiroko GojiShinji OharaKoichi HagiwaraTakashi KamadaKoji IidaNobutsune IshikawaHideaki ShiraishiOsato IwataHidenori SuganoYasushi IimuraTakuichiro HigashiHiroshi HosoyamaRyosuke HanayaAkihiro ShimotakeTakayuki KikuchiTakeshi YoshidaHiroshi ShigetoJun YokoyamaTakahiko MukainoMasaaki KatoMasanori SekimotoMasahiro MizobuchiYoko AburakawaMasaki IwasakiEiji NakagawaTomohiro IwataKentaro TokumotoTakuji NishidaYukitoshi TakahashiKenjiro KikuchiRyuki MatsuuraShin-Ichiro HamanoAyataka FujimotoHideo EnokiKyoichi TomotoMasako WatanabeYouji TakuboToshihiko FukuchiHidetoshi NakamotoYuichi KubotaNaoto KuniiYuichiro ShirotaEiichi IshikawaNobukazu NakasatoTaketoshi MaeharaMotoki InajiShunsuke TakagiTakashi EnokizonoYosuke MasudaTakahiro HayashiPublished in: Epilepsia open (2022)
We demonstrated the significant impact that the COVID-19 pandemic had on epilepsy care. These results support those of previous studies and clarify the effect size of each pandemic-related factor on epilepsy care.